Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of ROCHE is 0.6% (low). The company has been active since 1924 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Trust signals
2 signalsAdministrative Flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 09-06-2026 | 2026-00148910 |
| 31-12-2024 | volledig | 17-06-2025 | 2025-00143701 |
| 31-12-2023 | volledig | 10-06-2024 | 2024-00117960 |
| 31-12-2022 | volledig | 09-05-2023 | 2023-00085083 |
| 31-12-2021 | volledig | 29-04-2022 | 2022-20016425 |
| 31-12-2020 | volledig | 28-04-2021 | 2021-11600579 |
| 31-12-2019 | volledig | 07-05-2020 | 2020-11800451 |
| 31-12-2018 | volledig | 29-04-2019 | 2019-10900446 |
| 31-12-2017 | volledig | 03-05-2018 | 2018-12200529 |
| 31-12-2016 | volledig | 28-04-2017 | 2017-10900117 |
Directors
Directors & mandates
26 directors-
Current01-11-2022 → present
-
Current01-07-2022 → present
-
Current01-05-2022 → present
2 events
- 01-05-2022 Appointed· Director
- 01-05-2022 Appointed· Managing director
-
Current01-03-2022 → present
Historic, not recently confirmed (8)
-
Not recently confirmedlast confirmed in an act from 2020
-
Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2014
-
Not recently confirmedlast confirmed in an act from 2013
4 events
- 26-06-2013 Mandate renewed· Director
- 01-06-2013 Resigned· Director
- 21-02-2013 Appointed· Director
- 24-12-2007 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2007
2 events
- 24-12-2007 Mandate renewed· Director
- 11-07-2005 Mandate renewed· Managing director
-
Not recently confirmedlast confirmed in an act from 2007
-
Not recently confirmedlast confirmed in an act from 2007
2 events
- 24-12-2007 Mandate renewed· Director
- 11-07-2005 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2005
Former directors (14)
-
Former- → 06-06-2024
-
Former- → 01-11-2022
-
Former10-11-2021 → 01-07-2022
2 events
- 01-07-2022 Resigned· Director
- 10-11-2021 Appointed· Director
-
Former- → 01-05-2022
-
Former01-12-2018 → 01-03-2022
3 events
- 01-03-2022 Resigned· Daily management
- 01-12-2018 Appointed· Director
- 01-12-2018 Appointed· Managing director
-
Former- → 10-11-2021
-
Former26-06-2013 → 01-01-2020
5 events
- 01-01-2020 Resigned· Director
- 10-03-2014 Appointed· Director
- 01-09-2013 Resigned· Director
- 26-06-2013 Mandate renewed· Director
- 25-04-2013 Resigned· Managing director
-
Former01-01-2016 → 01-12-2018
4 events
- 01-12-2018 Resigned· Director
- 01-12-2018 Resigned· Managing director
- 01-01-2016 Appointed· Director
- 01-01-2016 Appointed· Managing director
-
Former01-06-2013 → 01-04-2017
2 events
- 01-04-2017 Resigned· Director
- 01-06-2013 Appointed· Director
-
Former01-09-2015 → 01-01-2016
2 events
- 01-01-2016 Resigned· Director
- 01-09-2015 Appointed· Director
-
Former25-04-2013 → 01-09-2015
3 events
- 01-09-2015 Resigned· Director
- 01-09-2015 Resigned· Managing director
- 25-04-2013 Appointed· Director
-
Former01-09-2013 → 10-03-2014
2 events
- 10-03-2014 Resigned· Director
- 01-09-2013 Appointed· Director
-
Former- → 11-02-2013
-
Former- → 24-12-2007
Statutory auditor
6 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Bedrijfsrevisoren BV/SRLCurrent Statutory auditor · represented by Ellemarie Bex |
- | 28-11-2025 → present |
| Klynveld Peat Marwick Goerdeler - Réviseurs d'Entreprises SCRL Civile Statutory auditor · represented by Karel Tanghe |
- | - → 15-06-2011 |
| KPMG Bedrijfsrevisoren CVBA Statutory auditor · represented by Olivier Declercq succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE SCRL in 2016 |
- | 24-12-2007 → 03-06-2016 |
| KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL Statutory auditor · represented by Tanguy Legein succeeded by KPMG Bedrijfsrevisoren BV/SRL in 2025 |
- | 30-06-2023 → 28-11-2025 |
| KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE SCRL Statutory auditor · represented by Axel Jorion succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL in 2023 |
- | 03-06-2016 → 30-06-2023 |
| KPMG Réviseurs d'Entreprises SCRL civile Statutory auditor · represented by Axel Jorion succeeded by KPMG BEDRIJFSREVISOREN REVISEURS D'ENTREPRISE BV/SRL in 2023 |
- | 31-05-2017 → 30-06-2023 |
Insolvency mandates
Legal Structure
| NACE primary | Vervaardiging van geneesmiddelen(21201) |
| Legal form | Public limited company(014) |
| Incorporation | 12-02-1924 |
| Status | Active |
| Postal code | 1070 |
Structure & network
Locations & real estate
Establishment units
2 locationsReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21306C0225/00C002 | Brussels | 1.2 ha | 1 · 1,356 m² | 19.1 m · 5 fl. |
| 23015B0120/00E000 | Flanders | 9,322 m² | 1 · 1,390 m² | 26.6 m · 7 fl. |
Publications
Lifecycle & Insolvency Signals
Belgisch Staatsblad · acts
44 acts28-11-2025 Ellemarie Bex reappointed as statutory auditor
22-07-2025 Board meeting · Statute amendment · General meeting · Officer appointment
- Publication: 22/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 11/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 23/04/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: wijziging delegatiereglement dagelijks bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 11/06/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Almirall N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Novo Nordisk Pharma N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · MSD Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Roche N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · UCB Pharma N.V.
- Officer resignation: role: bestuurder, end_date: 2025-06-11 · Vertex Pharmaceuticals (Netherlands) BV
- Permanent representative: start_date: 16/05/2025 · Paul Lacante
- Permanent representative · Gregory Paton
- Permanent representative · Axel De Muyt
- Permanent representative · Bruno Rabilier
31-01-2025 Change in the board of directors
18-07-2024 Tanguy Legein resigns as permanent representative
19-04-2024 Change in the board of directors
19-01-2024 Articles of association amended
30-06-2023 Tanguy Legein reappointed as statutory auditor
04-01-2023 4 directors appointed, 3 resigning
- Maria Johanna Borst, Bestuurder
- Maria Johanna Borst, Gedelegeerd bestuurder
- Isabelle Decker, Bestuurder
- Isabel Boissonnas, Bestuurder
- Ehab Youssef, Gedelegeerd bestuurder
- Harald Borrmann, Bestuurder
- Beat Krähenmann, Bestuurder
18-03-2022 1 director appointed, 1 resigning, 1 reappointed
- Ehab Abdelmoneim Youssef, Dagelijks bestuur
- Brigitte Nolet, Dagelijks bestuur
- Tanguy Legein, Commissaris
17-01-2022 1 director appointed, 1 resigning
- Harald Borrmann, Bestuurder
- Anna-Maria Heuchel-Reinig, Bestuurder
19-11-2021 Change in the board of directors
25-02-2021 Change in the board of directors
07-08-2020 Change in the board of directors
16-03-2020 1 director appointed, 1 resigning
17-12-2019 Change in the board of directors
12-08-2019 Axel Jorion reappointed as statutory auditor
09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 09/07/2019
- Filing: 28/06/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · MSD Belgium N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Roche N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · Chiesi N.V.
- Officer reappointment: date: 2019-03-27, role: Raad van Bestuur · UCB Pharma N.V.
- Board meeting: 24/04/2019
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Officer resignation: date: 2019-04-24, role: ondervoorzitter van de Raad van Bestuur · MSD Belgium N.V.
- Permanent representative · Clarisse Lhoste
- Officer appointment: role: CEO belast met het dagelijks bestuur · Catherine Rutten
09-07-2019 General meeting · Officer reappointment · Board meeting · Officer appointment
- Publication: 2019
- Filing: 28/05/2019
- General meeting: 27/03/2019
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · MSD Belgium S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Roche S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · Chiesi S.A.
- Officer reappointment: date: 2019-03-27, role: Membre du Conseil d'administration · UCB Belgium S.A.
- Board meeting: 24/04/2019
- Officer appointment: role: Vice-Président du Conseil d'administration, start_date: 2019-04-24 · Celgene
- Permanent representative · Michel Collard
- Permanent representative · Clarisse Lhoste
15-03-2019 Change in the board of directors
18-01-2019 2 directors appointed, 2 resigning
- Brigitte Nolet, Bestuurder
- Brigitte Nolet, Gedelegeerd bestuurder
- Priya Ratnam, Bestuurder
- Priya Ratnam, Gedelegeerd bestuurder
Analysis
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountSimilar
Similar companies
Same sector, nearest firstCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | ROCHE |